Our Products
We have a portfolio of rapid point-of-care tests for early disease detection and assessment of response to therapeutics.
Today, our portfolio addresses:
Maternal health
- Preeclampsia
- Gestational diabetes
Autoimmune
- Rheumatoid arthritis
- COVID antibodies
Lumella®
The Lumella® test estimates the concentration of Glycosylated Fibronectin, a new pregnancy specific biomarker to accurately assess the risk of preeclampsia.
Insudex®
The first and only point-of-care tests for early detection of type-1 diabetes and LADA (Latent Autoimmune Diabetes in Adults).
Glucema®
Introducing Glucema®
Non-invasive Diabetes Testing and Monitoring
The first and only point-of-care saliva test for diabetes monitoring.
RAprime
Rapid point-of-care tests for rheumatoid arthritis screening, diagnosis, and intervention.
